PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses
Visit https://www.peervoice.com/PHC860 to view the entire programme with slides. After completing “Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses”, participants will be able to: Recognise the unmet needs in patients with advanced gastric and oesophageal cancers and the role of emerging data related to targeted treatments, immunotherapy, and combinations in addressing these unmet needs; Describe key efficacy and safety data for targeted therapies, including multikinase inhibitors and immunotherapy in advanced gastric and oesophageal cancers; and Evaluate the potential impact and clinical implications of new evidence on the current treatment landscape in advanced gastric and oesophageal cancers.